• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD RESURFACING FEMORAL HEAD 54MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD RESURFACING FEMORAL HEAD 54MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Model Number 74121154
Device Problem Compatibility Problem (2960)
Patient Problem Injury (2348)
Event Date 01/01/1901
Event Type  Injury  
Event Description
It was reported that the patient underwent a left hip primary surgery for a bhr resurfacing on (b)(6) 2002 at (b)(6).On (b)(6) 2019 the patient received a confirmation of his cobalt poisoning due to the implants.The patient reported that a treatment including the removal of the devices took place with a different surgeon, nevertheless no explantation dates were provided.The patient outcome is unknown.
 
Manufacturer Narrative
It was reported that left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the bhr cup and femoral head was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.No other similar complaints were identified for the femoral head and for the bhr cup.In the absence of the actual devices, the production records for the available dhr were reviewed for the devices reportedly involved in this incident.All the released devices involved met manufacturing specifications at the time of production.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed for the alleged failure mode.No additional risks were identified as result of the reported event.No further actions are required at this time.The available medical documents were reviewed.It was reported that the patient underwent a left hip primary surgery for a bhr resurfacing on (b)(6) 2002.On (b)(6) 2019 the patient received a confirmation of his cobalt poisoning due to the implants.The patient reported that a treatment including the removal of the devices took place with a different surgeon.The patient outcome is unknown.Smith and nephew has not received the device/adequate materials to fully evaluate the complaint, but if additional clinically relevant materials are later received, then the case may be re-opened for further evaluation.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Manufacturer Narrative
It was reported that left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the bhr cup and femoral head was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.No other similar complaints were identified for the femoral head and for the bhr cup.In the absence of the actual devices, the production records for the available dhr were reviewed for the devices reportedly involved in this incident.All the released devices involved met manufacturing specifications at the time of production.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed for the alleged failure mode.No additional risks were identified as result of the reported event.No further actions are required at this time.The available medical documents were reviewed.It was reported that the patient underwent a left hip primary surgery for a bhr resurfacing on (b)(6) 2002.On (b)(6) 2019 the patient received a confirmation of his cobalt poisoning due to the implants.The patient reported that a treatment including the removal of the devices took place with a different surgeon.The patient outcome is unknown.Smith and nephew has not received the device/adequate materials to fully evaluate the complaint, but if additional clinically relevant materials are later received, then the case may be re-opened for further evaluation.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESURFACING FEMORAL HEAD 54MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house
spa park
leamington spa CV31 3HL
UK  CV31 3HL
MDR Report Key10383060
MDR Text Key202163795
Report Number3005975929-2020-00285
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502803
UDI-Public03596010502803
Combination Product (y/n)N
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Type of Report Initial,Followup,Followup
Report Date 10/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number74121154
Device Catalogue Number74121154
Device Lot Number21888
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/15/2020
Initial Date FDA Received08/08/2020
Supplement Dates Manufacturer Received08/21/2020
10/01/2020
Supplement Dates FDA Received08/25/2020
10/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-